Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Active, Not Recruiting

Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC

NCT04919811

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • The Oncology Institute of Hope and Innovation Glendale, California, United States
  • Moores Cancer Center at UC San Diego La Jolla, California, United States
  • Keck Medicine of University of Southern California Los Angeles, California, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations

NCT05103605

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Abbeville, France
  • Research Site Aix-en-Provence, France
  • Research Site Angers, France
  • Research Site Antibes, France
View all 46 locations
View Trial Details
Active, Not Recruiting

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

NCT03999710

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • Baptist Alliance Miami Cancer Institute Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy

NCT05781308

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CH Avignon Avignon, France
  • CH Côte Basque Bayonne, France
View all 44 locations
View Trial Details
Active, Not Recruiting

ENCOrafenib With Binimetinib in bRAF NSCLC

NCT04526782

Conditions
BRAF V600E, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Annemasse - CH Ambilly, France
  • Angers - CHU Angers, France
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Bordeaux - Institut Bergonié Bordeaux, France
View all 36 locations
View Trial Details
Active, Not Recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK)

NCT05200481

Conditions
ALK Gene Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • CHU d'Angers Angers, France
  • CHU Besançon - Hôpital J. MINJOZ Besançon, France
  • Hôpital APHP Ambroise Paré Boulogne, France
  • Hospices Civils de Lyon - Hôpital Louis Pradel Bron, France
View all 29 locations
View Trial Details

Related conditions